Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors

Chemico-Biological Interactions

Volumn 203, Issue 1, 2013, Pages 226-230

  Tsurkan, Lyudmila G ^a   Hatfield, M Jason ^a   Edwards, Carol C ^a   Hyatt, Janice L ^a   Potter, Philip M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Carbamate; Carboxylesterase; Cholinesterase; Inhibitor

Indexed keywords

ACETYLCHOLINESTERASE; CARBAMIC ACID DERIVATIVE; CARBOXYLESTERASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; RIVASTIGMINE; TACRINE;

CONFERENCE PAPER; CONTROLLED STUDY; ENZYME INHIBITION; INTESTINE; LIVER; STRUCTURAL HOMOLOGY;

CARBOXYLESTERASE; CARBOXYLIC ESTER HYDROLASES; CHOLINESTERASE INHIBITORS; DRUG INTERACTIONS; HUMANS; INTESTINES; KINETICS; LIVER; MODELS, MOLECULAR; PHENYLCARBAMATES; PHYSOSTIGMINE; RECOMBINANT PROTEINS;

EID: 84875805771     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.10.018     Document Type: Conference Paper

References (17)

1. G.L. Ellman, K.D. Courtney, V. Anders, and R.M. Featherstone A new and rapid colorimetric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
2. M. Grima, C. Welsch, B. Michel, M. Barthelmebs, and J.L. Imbs In vitro tissue potencies of converting enzyme inhibitors prodrug activation by kidney esterase Hypertension 17 1991 492 496
3. R.C. Gupta, and W.D. Dettbarn Role of carboxylesterases in the prevention and potentiation of N-methylcarbamate toxicity Chem. Biol. Interact. 87 1993 295 303
4. M.J. Hatfield, L. Tsurkan, M. Garrett, T. Shaver, C.C. Edwards, J.L. Hyatt, L.D. Hicks, and P.M. Potter Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11 Biochem. Pharamcol. 81 2011 24 31
5. M.J. Hatfield, L. Tsurkan, J.L. Hyatt, X. Yu, C.C. Edwards, L.D. Hicks, R.M. Wadkins, and P.M. Potter Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin Br. J. Pharmacol. 160 2010 1916 1928
6. J.L. Hyatt, T. Moak, J.M. Hatfield, L. Tsurkan, C.C. Edwards, M. Wierdl, M.K. Danks, R.M. Wadkins, and P.M. Potter Selective inhibition of carboxylesterases by isatins, indole-2,3-diones J. Med. Chem. 50 2007 1876 1885
7. R. Khanna, C.L. Morton, M.K. Danks, and P.M. Potter Proficient metabolism of CPT-11 by a human intestinal carboxylesterase Cancer Res. 60 2000 4725 4728
8. C.L. Morton, and P.M. Potter Comparison of Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, Spodoptera frugiperda and COS7 cells for recombinant gene expression: application to a rabbit liver carboxylesterase Mol. Biotechnol. 16 2000 193 202
9. D. Munoz-Torrero Acetylcholinesterase inhibitors as disease-modifying therapies for Alzheimer's disease Curr. Med. Chem. 15 2008 2433 2455
10. P.M. Potter, C.A. Pawlik, C.L. Morton, C.W. Naeve, and M.K. Danks Isolation and partial characterization of a cDNA encoding a rabbit liver carboxylesterase that activates the prodrug irinotecan (CPT-11) Cancer Res. 52 1998 2646 2651
11. M.R. Redinbo, S. Bencharit, and P.M. Potter Human carboxylesterase 1: from drug metabolism to drug discovery Biochem. Soc. Trans. 31 2003 620 624
12. M.R. Redinbo, and P.M. Potter Mammalian carboxylesterases: from drug targets to protein therapeutics Drug Discovery Today 10 2005 313 325
13. H. Schwer, T. Langmann, R. Daig, A. Becker, C. Aslanidis, and G. Schmitz Molecular cloning and characterization of a novel putative carboxylesterase, present in human intestine and liver Biochem. Biophys. Res. Commun. 233 1997 117 120
14. D. Shi, J. Yang, D. Yang, E.L. LeCluyse, C. Black, L. You, F. Akhlaghi, and B. Yan Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel J. Pharmacol. Exp. Ther. 319 2006 1477 1484
15. M. Tang, M. Mukundan, J. Yang, N. Charpentier, E.L. LeCluyse, C. Black, D. Yang, D. Shi, and B. Yan Antiplatelet agents aspirin and clopidogrel are hydrolyzed by distinct carboxylesterases, and clopidogrel is transesterificated in the presence of ethyl alcohol J. Pharmacol. Exp. Ther. 319 2006 1467 1476
16. R.M. Wadkins, J.L. Hyatt, X. Wei, K.J. Yoon, M. Wierdl, C.C. Edwards, C.L. Morton, J.C. Obenauer, K. Damodaran, P. Beroza, M.K. Danks, and P.M. Potter Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases J. Med. Chem. 48 2005 2905 2915
17. R.M. Wadkins, J.L. Hyatt, K.J. Yoon, C.L. Morton, R.E. Lee, K. Damodaran, P. Beroza, M.K. Danks, and P.M. Potter Identification of novel selective human intestinal carboxylesterase inhibitors for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activity Mol. Pharmacol. 65 2004 1336 1343